Hydroxy-9-methyl-2-Ellipticinium (NSC 264-137) in 52 cases of osseous metastases from breast cancer. | Eur J Cancer (1965);Suppl 1: 277-9, 1980. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Hydroxy-9-methyl-2-Ellipticinium (NSC 264-137) in 52 cases of osseous metastases from breast cancer.

Juret, P; Le Talaer, Y; Couette, J E; Delozier, T.

Eur J Cancer (1965) ; Suppl 1: 277-9, 1980.

Article in En | MEDLINE | ID: mdl-7032940

Subject(s)

Alkaloids/therapeutic use; Bone Neoplasms/secondary; Breast Neoplasms/drug therapy; Ellipticines/therapeutic use; Bone Neoplasms/drug therapy; Calcification, Physiologic; Clinical Trials as Topic; Female; Humans; Middle Aged

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms / Ellipticines / Alkaloids Limits: Female / Humans / Middle aged Language: En Journal: Eur J Cancer (1965) Year: 1980 Document type: Article Country of publication: United kingdom

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms / Ellipticines / Alkaloids Limits: Female / Humans / Middle aged Language: En Journal: Eur J Cancer (1965) Year: 1980 Document type: Article Country of publication: United kingdom